# Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

> **NCT06440694** · PHASE3 · RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 150 (estimated)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Colchicine 0.5 mg po
- **DRUG:** Placebo 0.5 mg po

## Key facts

- **NCT ID:** NCT06440694
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06440694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06440694, "Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06440694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*